Semnur Pharmaceuticals, Inc.

SMNR

Financials

10-QQ2 ended 06/30/2608/10/26 10-QQ1 ended 03/31/2605/13/26 10-KFY 202502/27/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/15/25

Disclosures

8-KCurrent report07/07/26 8-KCurrent report06/25/26 8-KCurrent report04/23/26 8-KCurrent report03/17/26 8-KCurrent report12/03/25

Prospectuses and Registrations

424B3Prospectus07/07/26 424B3Prospectus07/01/26 424B3Prospectus06/15/26 424B3Prospectus06/15/26 POS AMPost-effective amendment05/12/26

Proxies

DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials08/22/25 DEF 14ADefinitive proxy03/27/25 PRER14APreliminary proxy (revised)03/25/25 PRE 14APreliminary proxy03/20/25

Ownership

Form 3Initial insider ownership09/26/25 Form 3Initial insider ownership09/23/25 Form 3Initial insider ownership09/23/25 Form 3Initial insider ownership09/23/25 Form 3Initial insider ownership09/23/25

Other

EFFECTRequest for effectiveness05/18/26 ARSAnnual report to shareholders04/30/26 EFFECTRequest for effectiveness12/29/25 CORRESPCorrespondence with the SEC12/23/25 42542508/22/25